Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
59.33
-1.00 (-1.66%)
Official Closing Price
Updated: 7:00 PM EST, Jan 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
15,841,937
Open
59.93
Bid (Size)
59.00 (100)
Ask (Size)
59.10 (200)
Prev. Close
60.33
Today's Range
58.80 - 59.93
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
1.97%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Beaten-Down Growth Stocks Ready to Bounce Back
↗
January 28, 2026
Both companies are trading at attractive valuations today.
Via
The Motley Fool
1 Biotech Stock Set to Rebound in 2026
↗
January 28, 2026
The Wegovy maker is coming off a dismal showing in 2025, but it's a legitimate 2026 rebound candidate.
Via
The Motley Fool
Performance
YTD
+13.2%
+13.2%
1 Month
+15.8%
+15.8%
3 Month
+18.6%
+18.6%
6 Month
+26.0%
+26.0%
1 Year
-29.4%
-29.4%
More News
Read More
1 Pharmaceutical Stock Set to Rebound in 2026
↗
January 27, 2026
Via
The Motley Fool
2 Pharmaceutical Stocks Set to Rebound in 2026
↗
January 27, 2026
Via
The Motley Fool
Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week
↗
January 23, 2026
Via
Stocktwits
Where Will Eli Lilly Be in 10 Years?
↗
January 27, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker?
↗
January 26, 2026
Via
The Motley Fool
Prediction: This Healthcare Stock Could Soar by 40% in 2026
↗
January 26, 2026
Via
The Motley Fool
3 Growth Stocks to Invest $1,000 in Right Now
↗
January 24, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Should You Dump Eli Lilly's Shares After This Setback?
↗
January 24, 2026
Via
The Motley Fool
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
January 23, 2026
Via
Finterra
Topics
Intellectual Property
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
↗
January 23, 2026
Via
The Motley Fool
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
January 22, 2026
Via
MarketMinute
Topics
Economy
VIX Tumbles as Trump Rescinds Greenland Tariff Threats
January 22, 2026
Via
MarketMinute
Topics
Bonds
Government
Stocks
Arctic Ultimatum: Trump’s Greenland Tariff Threat Triggers $4,700 Gold Surge and 870-Point Dow Plunge
January 21, 2026
Via
MarketMinute
Topics
Economy
Government
Stocks
2 Top Stocks to Double Up On Right Now
↗
January 20, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic
↗
January 20, 2026
Via
Stocktwits
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
↗
January 20, 2026
Via
The Motley Fool
Is Oral Wegovy a Game Changer for Novo Nordisk?
↗
January 20, 2026
Via
The Motley Fool
Arctic Chill: Global Markets Reeling as Trump Demands Greenland Purchase with Massive Tariff Threats
January 20, 2026
Via
MarketMinute
Topics
Economy
Government
Stocks
The Arctic Gambit: Trump’s National Security Push for Greenland Sparks Diplomatic Crisis and Market Volatility
January 19, 2026
Via
MarketMinute
Topics
Economy
Electric Vehicles
Government
The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
↗
January 19, 2026
Via
MarketBeat
Topics
ETFs
Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
January 19, 2026
Via
Finterra
Topics
Economy
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 59.33
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/29/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.